Dignify Therapeutics

About:

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

Website: http://dignifytherapeutics.com

Twitter/X: DignifyDrug

Top Investors: RA Capital Management, National Institutes of Health, National Institute on Aging, North Carolina Biotechnology Center, National Institute of Diabetes and Digestive and Kidney Diseases

Description:

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal cord injured, multiple sclerosis and similar patient populations. By combining novel pharmaceutical agents with drug delivery technology, Dignify Therapeutics will redefine the treatment of these disorders and restore the dignity of voluntary excretory function for these patients. The company was founded in 2013 and is headquartered in Raleigh, North Carolina.

Total Funding Amount:

$10.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)dignifytherapeutics.com

Founders:

Aura Kullmann, Benny Ward, Dan Ricca, Eboo Versi, Ed Burgard, Karl Thor, Lesley Marson, Mary Katofiasc, Tatyana Touzova, Velu Karicheti

Number of Employees:

1-10

Last Funding Date:

2024-09-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai